LENSAR, Inc. announced its first quarter 2025 financial results on May 8, 2025, reporting total revenue of $14.2 million, a 34% increase compared to $10.6 million in the first quarter of 2024. This growth was primarily driven by increased system sales and a 33% rise in worldwide procedure volumes.
The company placed 14 ALLY Systems during the quarter, increasing the ALLY installed base to approximately 150 systems and the total combined installed base to approximately 395. LENSAR's laser systems performed approximately 22% of total U.S. procedures in the quarter.
While the net loss for the quarter was $27.3 million, this was predominantly due to a $26.6 million non-cash charge related to the change in warrant liability, resulting from a 58% increase in the company's stock price. Adjusted EBITDA for the quarter was positive at $0.2 million, and LENSAR received a $10.0 million cash deposit related to the Alcon merger.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.